Eli Lilly Pauses COVID-19 Study; Latest Acquisition Provides Potential To Target Large Markets

Eli Lilly (LLY) had its Covid-19 study paused over possible safety concerns. Enrollment is paused for now and this study hangs in the balance of whether or not it will resume. The good news is that t… [read more]

Leave a Comment